BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2573369)

  • 1. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
    Beaufils M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserving the autoregulation of renal hemodynamics.
    Beaufils M
    Cardiology; 1993; 83 Suppl 1():10-5. PubMed ID: 7903210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tertatolol on renal function in the isolated perfused rat kidney.
    Perico N; Remuzzi G
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):223S-227S. PubMed ID: 2573368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tertatolol on glomerular hemodynamics in the normal Munich-Wistar rat.
    Gabbai FB; Peterson OW; Prost JF; Blantz RC
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):213S-218S. PubMed ID: 2573366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive action of beta-adrenoceptor blocking drugs. The role of intrarenal mechanisms.
    Struyker-Boudier HA; Smits JF
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):237S-240S. PubMed ID: 2573370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
    Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP
    Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of cardiac output to the kidneys by tertatolol does not involve prostaglandins.
    Naeije R; Degaute JP
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):241S-244S. PubMed ID: 2573371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of renal function under chronic oral administration of labetalol.
    Labeeuw M; Zech P; Pozet N; Hadj-Aissa A; Traeger J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):23-5. PubMed ID: 3557725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.